Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI assessment of moderate versus deep neuromuscular blockade on abdominal working space during laparoscopic surgery
2017-003623-29Phase 4Completed
- Sponsor
- Radboudumc
- Start
- Dec 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex (3 arms), sponsored by Radboudumc. Primary endpoint: Skin - sacral promontory distance. Started Dec 2017; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2017-003623-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003623-29.